FI950818A - Uudet substituoidut sulfoniamidit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset - Google Patents

Uudet substituoidut sulfoniamidit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset Download PDF

Info

Publication number
FI950818A
FI950818A FI950818A FI950818A FI950818A FI 950818 A FI950818 A FI 950818A FI 950818 A FI950818 A FI 950818A FI 950818 A FI950818 A FI 950818A FI 950818 A FI950818 A FI 950818A
Authority
FI
Finland
Prior art keywords
compounds
preparation
pharmaceutical compositions
compositions containing
new substituted
Prior art date
Application number
FI950818A
Other languages
English (en)
Swedish (sv)
Other versions
FI110364B (fi
FI950818A0 (fi
Inventor
Jean-Louis Peglion
Jean-Paul Vilaine
Nicole Villeneuve
Jean-Pierre Iliou
Jean-Pierre Bidouard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of FI950818A0 publication Critical patent/FI950818A0/fi
Publication of FI950818A publication Critical patent/FI950818A/fi
Application granted granted Critical
Publication of FI110364B publication Critical patent/FI110364B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/60Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
    • C07C2603/66Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI950818A 1994-02-25 1995-02-22 Uudet substituoidut sulfoniamidit ja niitä sisältävät farmaseuttiset koostumukset FI110364B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9402159A FR2716679B1 (fr) 1994-02-25 1994-02-25 Nouvelles sulfonamides substituées, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
FR9402159 1994-02-25
US39345295 1995-02-23
US08/393,452 US5565457A (en) 1994-02-25 1995-02-23 Substituted sulfonamides

Publications (3)

Publication Number Publication Date
FI950818A0 FI950818A0 (fi) 1995-02-22
FI950818A true FI950818A (fi) 1995-08-26
FI110364B FI110364B (fi) 2002-12-31

Family

ID=26230972

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950818A FI110364B (fi) 1994-02-25 1995-02-22 Uudet substituoidut sulfoniamidit ja niitä sisältävät farmaseuttiset koostumukset

Country Status (16)

Country Link
US (1) US5565457A (fi)
EP (1) EP0669322B1 (fi)
JP (1) JPH07258217A (fi)
CN (1) CN1053895C (fi)
AT (1) ATE184597T1 (fi)
AU (1) AU682428B2 (fi)
CA (1) CA2143249C (fi)
DE (1) DE69512104T2 (fi)
DK (1) DK0669322T3 (fi)
ES (1) ES2139156T3 (fi)
FI (1) FI110364B (fi)
FR (1) FR2716679B1 (fi)
GR (1) GR3031256T3 (fi)
NO (1) NO302571B1 (fi)
NZ (1) NZ270567A (fi)
ZA (1) ZA951577B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6339087B1 (en) 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
FR2804429B1 (fr) * 2000-01-31 2003-05-09 Adir Nouveaux derives de 4-sulfonamides piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2439634A1 (en) * 2001-03-01 2002-09-12 Technological Resources Pty Limited Benzene-1 2-diol mannich bases ligands polymers and method of selective metal ions removal
US20040266732A1 (en) * 2002-09-20 2004-12-30 Jorge Galvez Therapeutic agents, methods, and treatments
EP1616862A4 (en) * 2003-04-18 2008-07-16 Ono Pharmaceutical Co HETEROCYCLIC NITROGEN COMPOUND AND USE THEREOF

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527768A (en) * 1967-11-24 1970-09-08 Monsanto Co Sulfonamido coumarin compounds
JP2556722B2 (ja) * 1988-02-18 1996-11-20 興和株式会社 新規なスルホンアミド化合物
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
US5326870A (en) * 1991-02-13 1994-07-05 Asahi Kasei Kogyo Kabushiki Kaisha Substituted sulfonamide derivative and a pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
ZA951577B (en) 1995-12-12
FR2716679B1 (fr) 1996-04-05
NO950716D0 (no) 1995-02-24
GR3031256T3 (en) 1999-12-31
DE69512104D1 (de) 1999-10-21
NZ270567A (en) 1996-05-28
US5565457A (en) 1996-10-15
EP0669322A1 (fr) 1995-08-30
AU682428B2 (en) 1997-10-02
CA2143249C (fr) 2002-02-26
EP0669322B1 (fr) 1999-09-15
ES2139156T3 (es) 2000-02-01
ATE184597T1 (de) 1999-10-15
FI110364B (fi) 2002-12-31
FR2716679A1 (fr) 1995-09-01
AU1344995A (en) 1995-09-07
CN1053895C (zh) 2000-06-28
CN1120537A (zh) 1996-04-17
DE69512104T2 (de) 2000-04-20
NO950716L (no) 1995-08-28
DK0669322T3 (da) 2000-03-27
CA2143249A1 (fr) 1995-08-26
FI950818A0 (fi) 1995-02-22
NO302571B1 (no) 1998-03-23
JPH07258217A (ja) 1995-10-09

Similar Documents

Publication Publication Date Title
NO305988B1 (no) Nye pyridinforbindelser og farmasoeytiske sammensetninger som inneholder dem
FI950016A0 (fi) Heterosykliset yhdisteet lääkeaineena
AR025386A1 (es) Moduladores de los receptores activados del proliferador de peroxisomas
DE10199003I1 (de) Substituierte Thiazolidinionderivate
NO303118B1 (no) Forgrenede alkylamino-tiazolderivater, anvendelse av dem, farmas÷ytiske preparater som inneholder dem og mellomprodukter for fremstilling av dem
HRP20000406B1 (en) Arylpiperazines having activity at the serotonin 1a receptor
AU677868B2 (en) New naphthalene derivatives, processes for their preparation and the pharmaceutical compositions which contain them
MA23479A1 (fr) Imidazodiazepines, procedes pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation.
BR9704900A (pt) Compostos de vlavona processo para a sua preparação e composições farmacêuticas contendo os mesmos
FI960123A0 (fi) Uudet alkyloidut (hetero)sykliset yhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
MX9201020A (es) 6,9-bis(amino-substituidas)benzo[g]isoquinolin-5,10-dionas.
FI950818A0 (fi) Uudet substituoidut sulfoniamidit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
DK0553016T3 (da) Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem
AR029001A1 (es) Derivados de bencil-3,4-metilendioxicinamico y el uso de los mismos para la manufactura de un medicamento
FR2663029B1 (fr) Derives de benzothiazole, leur preparation et les medicaments les contenant.
DK702788D0 (da) Thioformamidderivater og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
PT98688A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-(2-cloro-1-hidroxietil)-4-metiltiazol
DE3066018D1 (en) Guanidine compounds, process for preparing them and compositions containing them
NO976101D0 (no) Nye ellipticinforbindelser, en fremgangsmåte ved deres fremstilling, samt farmasöytiske blandinger som inneholder dem

Legal Events

Date Code Title Description
MA Patent expired